SOUAD ENAKUAA: Open Payments
NPI 1043606619 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,073 in 157 payments from 31 companies in 2025. Trend: 2023 $2,739 · 2024 $3,168 · 2025 $3,073
Food & beverage: $3,073
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 8 | $447 |
| Novo Nordisk Inc | 16 | $362 |
| Corcept Therapeutics | 16 | $275 |
| RECORDATI_RARE_DISEASES_INC. | 9 | $228 |
| Dexcom, Inc. | 22 | $175 |
| Amgen Inc. | 19 | $165 |
| Ascendis Pharma Endocrinology Inc | 7 | $143 |
| ABBVIE INC. | 9 | $142 |
| Alexion Pharmaceuticals, Inc. | 3 | $99 |
| Sequel Med Tech, LLC | 4 | $98 |
Products named: Omnipod, Ozempic, Korlym, ISTURISA, Dexcom G6 Transmitter, Yorvipath, STRENSIQ, TWIIST.
Industry payments across TX — which companies pay providers there.
